Worldwide distribution of common IDUA pathogenic variants

Clin Genet. 2018 Jul;94(1):95-102. doi: 10.1111/cge.13224. Epub 2018 Apr 11.

Abstract

Mucopolysaccharidosis type I (MPS I) is a rare disorder caused by deleterious sequence variants in the α-L-iduronidase (IDUA) gene. More than 200 pathogenic variants have been described so far, but their frequencies have not yet been analyzed on a worldwide scale. To address this, we analyzed the genotypes of MPS I patients from 35 published studies papers. The most common pathogenic variant observed was p.Trp402Ter. With frequencies of up to 63%, it was the major allele in most European countries, America and Australia. The variant p.Gln70Ter was also frequent; it was found mainly in Northern and Eastern Europe. The most frequent variant in North African countries was p.Pro533Arg; in Morocco, it represented more than 90% of mutant alleles. Variants observed in East Asians were not found in Western populations, including c.1190-1G>A, p.Ala79Val, p.Leu346Arg and c.613_617dupTGCTC. Conversely, p.Trp402Ter and p.Pro533Arg were not found in patients from East Asia. In conclusion, the most common pathogenic IDUA variant in MPS I patients are p.Trp402Ter, p.Gln70Ter and p.Pro533Arg. Knowledge about the genetic background of MPS I for each population is essential when developing new genotype-targeted therapies, as well as to enable faster genetic analysis and improve patient management.

Keywords: IDUA; MPS I; mucopolysaccharidosis; mutational profile; p.Gln70Ter; p.Pro533Arg; p.Trp402Ter.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alleles
  • Amino Acid Substitution
  • Gene Frequency
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Genotype
  • Global Health
  • Humans
  • Iduronidase / genetics*
  • Mucopolysaccharidosis I / diagnosis
  • Mucopolysaccharidosis I / epidemiology
  • Mucopolysaccharidosis I / genetics
  • Phenotype

Substances

  • IDUA protein, human
  • Iduronidase